The DOI matches its Crossref record; 46 of the 46 references it cites were found in a registry or an index.
Pyruvate kinase M2 activators promote tetramer formation and suppress tumorigenesis
Open accessAbstract
Cancer cells engage in a metabolic program to enhance biosynthesis and support cell proliferation. The regulatory properties of pyruvate kinase M2 (PKM2) influence altered glucose metabolism in cancer. The interaction of PKM2 with phosphotyrosine-containing proteins inhibits enzyme activity and increases the availability of glycolytic metabolites to support cell proliferation. This suggests that high pyruvate kinase activity may suppress tumor growth. We show that expression of PKM1, the pyruvate kinase isoform with high constitutive activity, or exposure to published small-molecule PKM2 activators inhibits the growth of xenograft tumors. Structural studies reveal that small-molecule activators bind PKM2 at the subunit interaction interface, a site that is distinct from that of the endogenous activator fructose-1,6-bisphosphate (FBP). However, unlike FBP, binding of activators to PKM2 promotes a constitutively active enzyme state that is resistant to inhibition by tyrosine-phosphorylated proteins. These data support the notion that small-molecule activation of PKM2 can interfere with anabolic metabolism.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Indeed, activation of pyruvate kinase can inhibit cancer cell proliferation and tumor growth in some settings (Anastasiou et al., 2012; Kung et al., 2012; Walsh et al., 2010), but because pyruvate kinase expression is dispensable for the growth of some tumors (Cortes-Cros et al., 2013; Israelsen et al., 2013), whether pyruvate kinase activation will lead to durable responses remains an area of”
From Targeting Metabolism for Cancer Therapy (2017) · cites this paper as Anastasiou et al., 2012
In the citing paper
“Activating PKM2 by using small-molecule agonists increases PEP-to-pyruvate conversion, reducing the flux of glycolytic intermediates toward anabolic pathways and slowing tumor cell growth (56, 60).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [56]
In the citing paper
“PKM2 exists as either an inactive dimer or an active tetramer, and oscillation between these two states influences the ability of cells to maintain anabolic metabolism (56).”
From Fueling Immunity: Insights into Metabolism and Lymphocyte Function (2013) · cites this paper as [56]
In the citing paper
“In order to examine the functional relevance of PKM2 for LPS action we next examined the effect of two highly specific small-molecule PKM2 activators, TEPP-46 and DASA-58.”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
In the citing paper
“TEPP-46, but not DASA-58, is pharmacokinetically validated in vivo (Anastasiou et al., 2012).”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
In the citing paper
“These well-characterized and highly specific compounds bind PKM2, which then forms a tight tetramer with PKM1-like kinetic properties, an event that is resistant to inhibition by tyrosine phosphorylation.”
From Pyruvate kinase M2 regulates Hif-1α activity and IL-1β induction and is a critical determinant of the Warburg effect in LPS-activated macrophages (2015) · cites this paper as Anastasiou et al., 2012
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Berman, H. M. (2000) · Nucleic Acids Research · doi:10.1093/nar/28.1.235 · Cited by 40,196
[20] Processing of X-ray diffraction data collected in oscillation mode
Otwinowski, Z., & Minor, W. (1997) · Methods in Enzymology · doi:10.1016/s0076-6879(97)76066-x · Cited by 33,475
Features and development of Coot
Emsley, P., Lohkamp, B., Scott, W. G., & Cowtan, K. (2010) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444910007493 · Cited by 29,915
Colowick, S. P., Joshi, M. D., Jagannathan, & KAPLAN, N. O. (1966) · Cited by 26,137
Understanding the Warburg Effect: The Metabolic Requirements of Cell Proliferation
Vander Heiden, M. G., Cantley, L. C., & Thompson, C. B. (2009) · Science · doi:10.1126/science.1160809 · Cited by 16,197
Self-citationRefinement of Macromolecular Structures by the Maximum-Likelihood Method
Murshudov, G. N., Vagin, A. A., & Dodson, E. J. (1997) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444996012255 · Cited by 14,796
Targeting cancer cells by ROS-mediated mechanisms: a radical therapeutic approach?
Trachootham, D., Alexandre, J., & Huang, P. (2009) · Nature Reviews Drug Discovery · doi:10.1038/nrd2803 · Cited by 5,452
PRODRG: a tool for high-throughput crystallography of protein–ligand complexes
Schüttelkopf, A. W., & van Aalten, D. M. F. (2004) · Acta Crystallographica Section D Biological Crystallography · doi:10.1107/s0907444904011679 · Cited by 4,837
Regulation of cancer cell metabolism
Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744
The M2 splice isoform of pyruvate kinase is important for cancer metabolism and tumour growth
Christofk, H. R., Vander Heiden, M. G., Harris, M. H., Ramanathan, A., Gerszten, R. E., Wei, R., Fleming, M. D., Schreiber, S. L., & Cantley, L. C. (2008) · Nature · doi:10.1038/nature06734 · Cited by 2,820
Self-citation
Flagged first, then by citations
Cited by
Sorted by citations
Items 101–200 of 830
Oxidative Phosphorylation: A Target for Novel Therapeutic Strategies Against Ovarian Cancer
Nayak, A. P., Kapur, A., Barroilhet, L. M., & Patankar, M. S. (2018) · Cancers · doi:10.3390/cancers10090337 · Cited by 149
Canonical and non-canonical Hedgehog signalling and the control of metabolism
Teperino, R., Aberger, F., Esterbauer, H., Galdo, N. A. R., & Pospisilik, J. A. (2014) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2014.05.007 · Cited by 150
Targeting glucose metabolism enzymes in cancer treatment: current and emerging strategies
Zhang, Y., Li, Q., Huang, Z., Li, B., Nice, E. C., Huang, C., Wei, L., & Zou, B. (2022) · Cancers · doi:10.3390/cancers14194568 · Cited by 144
Systemic Immunometabolism: Challenges and Opportunities
Lercher, A., Baazim, H., & Bergthaler, A. (2020) · Immunity · doi:10.1016/j.immuni.2020.08.012 · Cited by 144
Post-translational modifications and the Warburg effect
Hitosugi, T., & Chen, J. (2013) · Oncogene · doi:10.1038/onc.2013.406 · Cited by 139
Sormendi, S., & Wielockx, B. (2018) · Frontiers in Immunology · doi:10.3389/fimmu.2018.00040 · Cited by 147
Identification of a multienzyme complex for glucose metabolism in living cells
Kohnhorst, C. L., Kyoung, M., Jeon, M., Schmitt, D. L., Kennedy, E. L., Ramirez, J., Bracey, S. M., Luu, B. T., Russell, S. J., & An, S. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.783050 · Cited by 138
Vallée, A., Guillevin, R., & Vallée, J.-N. (2017) · Reviews in the Neurosciences · doi:10.1515/revneuro-2017-0032 · Cited by 137
Wang, Z., Yin, J., Li, M., Shen, J., Xiao, Z., Zhao, Y., Huang, C.-L., Zhang, H., Zhang, Z., Cho, C. H., et al. (2019) · Chinese Medicine · doi:10.1186/s13020-019-0231-3 · Cited by 135
Structural insight into mechanisms for dynamic regulation of PKM2
Wang, P., Sun, C., Zhu, T., & Xu, Y. (2015) · Protein & Cell · doi:10.1007/s13238-015-0132-x · Cited by 130
Glycolysis, the sweet appetite of the tumor microenvironment
Kooshan, Z., Cárdenas-Piedra, L., Clements, J. A., & Batra, J. (2024) · Cancer Letters · doi:10.1016/j.canlet.2024.217156 · Cited by 135
Pyruvate Kinase M2 Activates mTORC1 by Phosphorylating AKT1S1
He, C.-L., Bian, Y., Xue, Y., Liu, Z., Zhou, K.-Q., Yao, C.-F., Lin, Y., Zou, H.-F., Luo, F.-X., Qu, Y.-Y., et al. (2016) · Scientific Reports · doi:10.1038/srep21524 · Cited by 130
Amin, S., Yang, P., & Li, Z. (2019) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2019.02.003 · Cited by 128
ASO-Based PKM Splice-Switching Therapy Inhibits Hepatocellular Carcinoma Growth
Ma, W. K., Voss, D. M., Scharner, J., Costa, A. S. H., Lin, K., Jeon, H. Y., Wilkinson, J. E., Jackson, M., Rigo, F., Bennett, C. F., et al. (2021) · Cancer Research · doi:10.1158/0008-5472.can-20-0948 · Cited by 130
Advances in high‐throughput mass spectrometry in drug discovery
Dueñas, M. E., Heap, R. E., Leveridge, M. V., Annan, R. S., Büttner, F. H., & Trost, M. (2022) · EMBO Molecular Medicine · doi:10.15252/emmm.202114850 · Cited by 128
Coordinating Bacterial Cell Division with Nutrient Availability: a Role for Glycolysis
Monahan, L. G., Hajduk, I. V., Blaber, S. P., Charles, I. G., & Harry, E. J. (2014) · mBio · doi:10.1128/mbio.00935-14 · Cited by 123
Allosteric Regulation of PKM2 Allows Cellular Adaptation to Different Physiological States
Gui, D. Y., Lewis, C. A., & Heiden, M. G. V. (2013) · Science Signaling · doi:10.1126/scisignal.2003925 · Cited by 124
PKM2 promotes pulmonary fibrosis by stabilizing TGF-β1 receptor I and enhancing TGF-β1 signaling
Gao, S., Li, X., Jiang, Q., Liang, Q. L., Zhang, F., Li, S., Zhang, R., Luan, J., Zhu, J., Gu, X., et al. (2022) · Science Advances · doi:10.1126/sciadv.abo0987 · Cited by 125
A DERL3-associated defect in the degradation of SLC2A1 mediates the Warburg effect
López-Serra, P., Marcilla, M., Villanueva, A., Ramos-Fernández, A., Palau, A., Leal, L., Wahi, J. E., Setien-Baranda, F., Szczęsna, K., Moutinho, C., et al. (2014) · Nature Communications · doi:10.1038/ncomms4608 · Cited by 118
Self-citationCrosstalk between the Warburg effect, redox regulation and autophagy induction in tumourigenesis
Gwangwa, M. V., Joubert, A. M., & Visagie, M. H. (2018) · Cellular & Molecular Biology Letters · doi:10.1186/s11658-018-0088-y · Cited by 120
Photoreceptor metabolic reprogramming: current understanding and therapeutic implications
Pan, W. W., Wubben, T. J., & Besirli, C. G. (2021) · Communications Biology · doi:10.1038/s42003-021-01765-3 · Cited by 126
Ning, X., Qi, H., Li, R., Li, Y., Jin, Y., McNutt, M. A., Liu, J., & Yin, Y. (2017) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2017.06.064 · Cited by 115
Digoxin Suppresses Pyruvate Kinase M2-Promoted HIF-1α Transactivation in Steatohepatitis
Ouyang, X., Han, S., Zhang, J., Dioletis, E., Németh, B. T., Pacher, P., Feng, D., Bataller, R. A., Cabezas, J., Stärkel, P., et al. (2018) · Cell Metabolism · doi:10.1016/j.cmet.2018.01.007 · Cited by 116
Non-metabolic functions of glycolytic enzymes in tumorigenesis
Yu, X., & Li, S. (2016) · Oncogene · doi:10.1038/onc.2016.410 · Cited by 114
Giannoni, E., Taddei, M. L., Morandi, A., Comito, G., Calvani, M., Bianchini, F., Richichi, B., Raugei, G., Wong, N., Tang, D., et al. (2015) · Oncotarget · doi:10.18632/oncotarget.4448 · Cited by 115
Targeting Cancer Metabolism - Revisiting the Warburg Effects
Tran, Q., Lee, H., Park, J., Kim, S., & Park, J. (2016) · Toxicological Research · doi:10.5487/tr.2016.32.3.177 · Cited by 116
Profiling metabolic networks to study cancer metabolism
Hiller, K., & Metallo, C. M. (2012) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2012.11.001 · Cited by 113
Self-citationEndothelial cell metabolism: parallels and divergences with cancer cell metabolism
Verdegem, D., Moens, S., Stapor, P. C., & Carmeliet, P. (2014) · Cancer & Metabolism · doi:10.1186/2049-3002-2-19 · Cited by 117
Cancer‐like metabolism of the mammalian retina
Ng, S. K., Wood, J. P., Chidlow, G., Han, G., Kittipassorn, T., Peet, D. J., & Casson, R. J. (2014) · Clinical and Experimental Ophthalmology · doi:10.1111/ceo.12462 · Cited by 113
PKM2 is the target of proanthocyanidin B2 during the inhibition of hepatocellular carcinoma
Feng, J., Wu, L., Ji, J., Chen, K., Yu, Q., Zhang, J., Chen, J., Mao, Y., Wang, F., Dai, W., et al. (2019) · Journal of Experimental & Clinical Cancer Research · doi:10.1186/s13046-019-1194-z · Cited by 109
l-Serine links metabolism with neurotransmission
Maugard, M., Vigneron, P.-A., Bolaños, J. P., & Bonvento, G. (2020) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2020.101896 · Cited by 106
Targeting glucose metabolism in patients with cancer
Elf, S., & Chen, J. (2013) · Cancer · doi:10.1002/cncr.28501 · Cited by 108
Lack of Evidence for PKM2 Protein Kinase Activity
Hosios, A. M., Fiske, B. P., Gui, D. Y., & Heiden, M. G. V. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.07.013 · Cited by 113
Self-citationTetrameric acetyl-CoA acetyltransferase 1 is important for tumor growth
Fan, J., Lin, R., Xia, S., Chen, D., Elf, S. E., Liu, S., Pan, Y., Xu, H., Qian, Z., Wang, M., et al. (2016) · Molecular Cell · doi:10.1016/j.molcel.2016.10.014 · Cited by 106
How metabolites modulate metabolic flux
Wegner, A., Meiser, J., Weindl, D., & Hiller, K. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.11.008 · Cited by 108
Liu, H., Takagaki, Y., Kumagai, A., Kanasaki, K., & Koya, D. (2020) · Journal of Diabetes Investigation · doi:10.1111/jdi.13478 · Cited by 110
Bettencourt, I. A., & Powell, J. D. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1601318 · Cited by 106
Zhou, Z., Li, M., Zhang, L., Zhao, H., Şahin, Ö., Chen, J., Zhao, J. J., Songyang, Z., & Yu, D. (2018) · Cancer Research · doi:10.1158/0008-5472.can-17-2726 · Cited by 102
Ma, T., Patel, H., Babapoor-Farrokhran, S., FRANKLIN, R. B., Semenza, G. L., Sodhi, A., & Montaner, S. (2015) · Angiogenesis · doi:10.1007/s10456-015-9475-4 · Cited by 101
Alterations in cancer cell metabolism: The Warburg effect and metabolic adaptation
Asgari, Y., Zabihinpour, Z., Salehzadeh‐Yazdi, A., Schreiber, F., & Masoudi‐Nejad, A. (2015) · Genomics · doi:10.1016/j.ygeno.2015.03.001 · Cited by 98
Protein kinase function of pyruvate kinase M2 and cancer
Chen, X., Chen, S., & Yu, D. (2020) · Cancer Cell International · doi:10.1186/s12935-020-01612-1 · Cited by 104
Regulation of Immune Cell Functions by Metabolic Reprogramming
Kim, J. (2018) · Journal of Immunology Research · doi:10.1155/2018/8605471 · Cited by 97
Shan, S., Shi, J., Yang, P., Jia, B., Wu, H., Zhang, X., & Li, Z. (2017) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.7b02757 · Cited by 98
Gupta, K. D., Shakespear, M. R., Curson, J. E. B., Murthy, A. M. V., Iyer, A., Hodson, M. P., Ramnath, D., Tillu, V. A., von Pein, J. B., Reid, R. C., et al. (2020) · Cell Reports · doi:10.1016/j.celrep.2020.02.007 · Cited by 101
Endothelial pyruvate kinase M2 maintains vascular integrity
Kim, B., Jang, C., Dharaneeswaran, H., Li, J., Bhide, M., Yang, S. H., Li, K., & Arany, Z. P. (2018) · Journal of Clinical Investigation · doi:10.1172/jci120912 · Cited by 91
The Role of PKM2 in Metabolic Reprogramming: Insights into the Regulatory Roles of Non-Coding RNAs
Puckett, D. L., Alquraishi, M. I., Chowanadisai, W., & Bettaieb, A. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22031171 · Cited by 95
Clinical significance of T cell metabolic reprogramming in cancer
Herbel, C., Patsoukis, N., Bardhan, K., Seth, P., Weaver, J. D., & Boussiotis, V. A. (2016) · Clinical and Translational Medicine · doi:10.1186/s40169-016-0110-9 · Cited by 99
An update on therapeutic opportunities offered by cancer glycolytic metabolism
Granchi, C., Fancelli, D., & Minutolo, F. (2014) · Bioorganic & Medicinal Chemistry Letters · doi:10.1016/j.bmcl.2014.09.041 · Cited by 94
Méndez‐Lucas, A., Li, X., Hu, J., Che, L., Song, X., Jia, J., Wang, J., Xie, C., Driscoll, P. C., Tschaharganeh, D. F., et al. (2017) · Cancer Research · doi:10.1158/0008-5472.can-17-0498 · Cited by 90
Reactive Oxygen Species, Metabolic Plasticity, and Drug Resistance in Cancer
Bhardwaj, V., & He, J. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21103412 · Cited by 88
A PKM2 signature in the failing heart
Rees, M. L., Subramaniam, J., Li, Y., Hamilton, D. J., Frazier, O. H., & Taegtmeyer, H. (2015) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2015.02.122 · Cited by 91
Yu, Z., Zhao, X., Huang, L., Zhang, T., Yang, F., Xie, L., Song, S., Miao, P., Zhao, L., Sun, X., et al. (2013) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.508226 · Cited by 92
Pyruvate Kinase M2 in Blood Circulation Facilitates Tumor Growth by Promoting Angiogenesis
Li, L., Zhang, Y., Qiao, J., Yang, J. J., & Liu, Z. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m114.576934 · Cited by 93
Mohammad, G. H., Damink, S. W. M. O., Malagó, M., Dhar, D. K., & Pereira, S. P. (2016) · PLoS ONE · doi:10.1371/journal.pone.0151635 · Cited by 93
Loss of pyruvate kinase M2 limits growth and triggers innate immune signaling in endothelial cells
Stone, O. A., El-Brolosy, M. A., Wilhelm, K., Liu, X., Romão, A. M., Grillo, E., Lai, J. K. H., Günther, S., Jeratsch, S., Kuenne, C. T., et al. (2018) · Nature Communications · doi:10.1038/s41467-018-06406-8 · Cited by 91
Benserazide is a novel inhibitor targeting PKM2 for melanoma treatment
Zhou, Y., Huang, Z., Su, J., Li, J., Zhao, S., Wu, L., Jiangling, Z., He, Y., Zhang, G., Tao, J., et al. (2019) · International Journal of Cancer · doi:10.1002/ijc.32756 · Cited by 88
Icard, P., & Lincet, H. (2016) · Drug Resistance Updates · doi:10.1016/j.drup.2016.09.003 · Cited by 86
The RNA-binding protein PTBP1 is necessary for B cell selection in germinal centers
Monzón‐Casanova, E., Screen, M., Díaz‐Muñoz, M. D., Coulson, R., Bell, S. E., Lamers, G., Solimena, M., Smith, C. W. J., & Turner, M. (2018) · Nature Immunology · doi:10.1038/s41590-017-0035-5 · Cited by 87
Saleme, B., Gurtu, V., Zhang, Y., Kinnaird, A. S., Boukouris, A. E., Gopal, K., Ussher, J. R., & Sutendra, G. (2019) · Science Translational Medicine · doi:10.1126/scitranslmed.aau8866 · Cited by 84
Toller-Kawahisa, J. E., Hiroki, C. H., Silva, C. M. S., Nascimento, D. C., Públio, G. A., Martins, T. V., Damasceno, L. E. A., Veras, F. P., Viacava, P. R., Sukesada, F. Y., et al. (2023) · Nature Communications · doi:10.1038/s41467-023-40021-6 · Cited by 90
The role of RNA alternative splicing in regulating cancer metabolism
Kozlovski, I., Siegfried, Z., Amar-Schwartz, A., & Karni, R. (2017) · Human Genetics · doi:10.1007/s00439-017-1803-x · Cited by 83
Mohammad, G. H., Vassileva, V., Acedo, P., Damink, S. W. M. O., Malagó, M., Dhar, D. K., & Pereira, S. P. (2019) · Cancers · doi:10.3390/cancers11091372 · Cited by 88
Kulkarni, P. P., Tiwari, A., Singh, N. K., Gautam, D., Sonkar, V. K., Agarwal, V., & Dash, D. (2018) · Haematologica · doi:10.3324/haematol.2018.205724 · Cited by 85
Role of pyruvate kinase M2-mediated metabolic reprogramming during podocyte differentiation
Yuan, Q., Miao, J., Yang, Q., Fang, L., Fang, Y., Ding, H., Zhou, Y., Jiang, L., Dai, C., Zen, K., et al. (2020) · Cell Death and Disease · doi:10.1038/s41419-020-2481-5 · Cited by 86
Wong, C. C., Au, S. L., Tse, A. P., Xu, M., Lai, R. K., Chiu, D. K., Wei, L. L., Fan, D. N.-Y., Tsang, F. H., Lo, R. C., et al. (2014) · PLoS ONE · doi:10.1371/journal.pone.0115036 · Cited by 87
PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis
Nguyen, A., Loo, J. M., Mital, R., Weinberg, E. M., Man, F. Y., Zeng, Z., Paty, P. B., Saltz, L. B., Janjigian, Y. Y., de Stanchina, E., et al. (2016) · Journal of Clinical Investigation · doi:10.1172/jci83587 · Cited by 84
Prudova, A., Gocheva, V., Keller, U. A. D., Eckhard, U., Olson, O. C., Akkari, L., Butler, G. S., Fortelny, N., Lange, P. F., Mark, J. C., et al. (2016) · Cell Reports · doi:10.1016/j.celrep.2016.06.086 · Cited by 83
Tyrosine Kinase Signaling in Cancer Metabolism: PKM2 Paradox in the Warburg Effect
Wiese, E. K., & Hitosugi, T. (2018) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2018.00079 · Cited by 83
Coassolo, S., Davidson, G., Négroni, L., Gambi, G., Daujat, S., Romier, C., & Davidson, I. (2021) · Nature Communications · doi:10.1038/s41467-021-21960-4 · Cited by 84
Zheng, D., Jiang, Y., Qu, C., Yuan, H., Hu, K., He, L., Chen, P., Li, J., Tu, M., Lin, L., et al. (2020) · American Journal Of Pathology · doi:10.1016/j.ajpath.2020.08.002 · Cited by 88
Purine nucleotide depletion prompts cell migration by stimulating the serine synthesis pathway
Soflaee, M. H., Kesavan, R., Sahu, U., Tasdogan, A., Villa, E., Djabari, Z., Cai, F., Tran, D. H., Vu, H., Ali, E. S., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-30362-z · Cited by 81
Self-citationRueda, E. M., Johnson, J. E., Giddabasappa, A., Swaroop, A., Brooks, M. J., Sigel, I., Chaney, S. Y., & Fox, D. A. (2016) · PubMed Central · Cited by 78
Prakasam, G., Singh, R. K., Iqbal, M. A., Saini, S. K., Tiku, A. B., & Bamezai, R. N. K. (2017) · Journal of Biological Chemistry · doi:10.1074/jbc.m117.791343 · Cited by 79
High Fructose Drives the Serine Synthesis Pathway in Acute Myeloid Leukemic Cells
Jeong, S., Savino, A. M., Chirayil, R., Barin, E., Cheng, Y., Park, S., Schurer, A., Mullarky, E., Cantley, L. C., Kharas, M. G., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.12.005 · Cited by 78
Self-citationMethionine oxidation activates pyruvate kinase M2 to promote pancreatic cancer metastasis
He, D., Feng, H., Sundberg, B., Yang, J., Powers, J., Christian, A. H., Wilkinson, J. E., Monnin, C., Avizonis, D. Z., Thomas, C. J., et al. (2022) · Molecular Cell · doi:10.1016/j.molcel.2022.06.005 · Cited by 80
Self-citationCoussens, N. P., Braisted, J. C., Peryea, T., Sittampalam, G. S., Simeonov, A. M., & Hall, M. D. (2017) · Pharmacological Reviews · doi:10.1124/pr.117.013755 · Cited by 80
Multiple functions of pyruvate kinase M2 in various cell types
Lee, Y.-B., Min, J. K., Kim, J., Cap, K. C., Islam, R., Hossain, A. J., Dogsom, O., Hamza, A., Mahmud, S., Choi, D. R., et al. (2021) · Journal of Cellular Physiology · doi:10.1002/jcp.30536 · Cited by 77
Zhang, Z., Zheng, Y., Chen, Y., Yin, Y., Chen, Y., Chen, Q., Hou, Y., Shen, S., Lv, M., & Wang, T. (2022) · Experimental Hematology and Oncology · doi:10.1186/s40164-022-00334-6 · Cited by 82
Snaebjornsson, M. T., & Schulze, A. (2018) · Experimental & Molecular Medicine · doi:10.1038/s12276-018-0065-6 · Cited by 79
O-GlcNAcase targets pyruvate kinase M2 to regulate tumor growth
Singh, J. P., Qian, K., Lee, J.-S., Zhou, J., Han, X., Zhang, B., Ong, Q., Ni, W., Jiang, M., Ruan, H., et al. (2019) · Oncogene · doi:10.1038/s41388-019-0975-3 · Cited by 78
Dong, T., Kang, X., Liu, Z., Zhao, S., Ma, W., Xuan, Q., Liu, H., Wang, Z., & Zhang, Q. (2015) · Tumor Biology · doi:10.1007/s13277-015-4729-8 · Cited by 78
Abulizi, A., CARDONE, R. L., Stark, R., Lewandowski, S. L., Zhao, X., Hillion, J., Ma, L., Sehgal, R., Alves, T. C., Thomas, C. J., et al. (2020) · Cell Metabolism · doi:10.1016/j.cmet.2020.10.006 · Cited by 74
Self-citationGlucose addiction in cancer therapy: advances and drawbacks
Granja, S., Pinheiro, C. M., Reis, R. M., Martinho, O., & Baltazar, F. (2015) · Current Drug Metabolism · doi:10.2174/1389200216666150602145145 · Cited by 74
Ye, G., Qin, Y. W., Wang, S., Pan, D., Xu, S., Wu, C., Wang, X., Wang, J., Ye, H., & Shen, H. (2019) · Cancer Biology & Therapy · doi:10.1080/15384047.2018.1564558 · Cited by 75
Metabolic reprogramming & inflammation: Fuelling the host response to pathogens
Gleeson, L. E., & Sheedy, F. J. (2016) · Seminars in Immunology · doi:10.1016/j.smim.2016.10.007 · Cited by 78
Links between cancer metabolism and cisplatin resistance
Cocetta, V., Ragazzi, E., & Montopoli, M. (2020) · International review of cytology · doi:10.1016/bs.ircmb.2020.01.005 · Cited by 77
How glucose, glutamine and fatty acid metabolism shape blood and lymph vessel development
Teuwen, L.-A. M. N., Geldhof, V., & Carmeliet, P. (2017) · Developmental Biology · doi:10.1016/j.ydbio.2017.12.001 · Cited by 75
Mechanism of PKM2 affecting cancer immunity and metabolism in Tumor Microenvironment
Chen, M., Liu, H., Li, Z., Ming, A. L., & Chen, H. (2021) · Journal of Cancer · doi:10.7150/jca.54430 · Cited by 76
Sensitizing the Therapeutic Efficacy of Taxol with Shikonin in Human Breast Cancer Cells
Li, W., Liu, J., Jackson, K. L., Shi, R., & Zhao, Y. (2014) · PLoS ONE · doi:10.1371/journal.pone.0094079 · Cited by 71
Pharmacologic Activation of PKM2 Slows Lung Tumor Xenograft Growth
Parnell, K. M., Foulks, J. M., Nix, R. N., Clifford, A., Bullough, J., LUO, B. H., Senina, A. V., Vollmer, D., Liu, J., McCarthy, V., et al. (2013) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-13-0026 · Cited by 73
Cheng, T., Yang, Y., Wang, H., Tien, Y., Shun, C., Huang, H., Hsiao, M., & Hua, K. (2018) · Oncogene · doi:10.1038/s41388-017-0086-y · Cited by 70
Nakatsu, D., Horiuchi, Y., Kano, F., Noguchi, Y., Sugawara, T., Takamoto, I., Kubota, N., Kadowaki, T., & Murata, M. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1417197112 · Cited by 68
The HMGB1 protein induces a metabolic type of tumour cell death by blocking aerobic respiration
Gdynia, G., Sauer, S. W., Kopitz, J., Fuchs, D., Duglova, K., Ruppert, T., Miller, M., Pahl, J. H. W., Cerwenka, A., Enders, M., et al. (2016) · Nature Communications · doi:10.1038/ncomms10764 · Cited by 71
Witney, T. H., James, M. L., Shen, B., Chang, E., Pohling, C., Arksey, N., Höhne, A., Shuhendler, A. J., Park, J. H., Bodapati, D., et al. (2015) · Science Translational Medicine · doi:10.1126/scitranslmed.aac6117 · Cited by 67
Zhou, Y., Niu, W., Luo, Y., Li, H., Xie, Y., Wang, H., Liu, Y., Fan, S., Li, Z., Xiong, W., et al. (2019) · Cancer Science · doi:10.1111/cas.13928 · Cited by 66
Wiese, E. K., Hitosugi, S., Loa, S. T., Sreedhar, A., Andres‐Beck, L. G., Kurmi, K., Pang, Y., Karnitz, L. M., Gonsalves, W. I., & Hitosugi, T. (2021) · Nature Metabolism · doi:10.1038/s42255-021-00424-5 · Cited by 67
Veras, F. P., Peres, R. S., Saraiva, A. L., Pinto, L. G., Louzada‐Júnior, P., Cunha, T. M., Paschoal, J. A. R., Cunha, F. Q., & Alves-Filho, J. C. (2015) · Scientific Reports · doi:10.1038/srep15171 · Cited by 66
McDonnell, S. R. P., Hwang, S. R., Rolland, D. C. M., Murga‐Zamalloa, C., Basrur, V., Conlon, K. P., Fermin, D., Wolfe, T., Raskind, A. B., Ruan, C., et al. (2013) · Blood · doi:10.1182/blood-2013-01-482026 · Cited by 65
Self-citationBoscá, L., González-Ramos, S., Prieto, P., Fernández‐Velasco, M., Mojena, M., Martín‐Sanz, P., & Alemany, S. (2015) · Biochemical Society Transactions · doi:10.1042/bst20150107 · Cited by 69
Calderon, F. A., Gregory, M. A., Pham‐Danis, C., DeRyckere, D., Stevens, B. M., Zaberezhnyy, V., Hill, A. A., Gemta, L. F., Kumar, A., Kumar, V., et al. (2014) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-2146 · Cited by 71
Metadata
- Authors
- Anastasiou, D., Yu, Y., Israelsen, W. J., Jiang, J.-K., Boxer, M. B., Hong, B. S., Tempel, W., Dimov, S., Shen, M., Jha, A., Yang, H., Mattaini, K. R., Metallo, C. M., Fiske, B. P., Courtney, K. D., Malstrom, S., Khan, T. M., Kung, C., Skoumbourdis, A. P., Veith, H., Southall, N., Walsh, M. J., Brimacombe, K. R., Leister, W., Lunt, S. Y., Johnson, Z. R., Yen, K. E., Kunii, K., Davidson, S. M., Christofk, H. R., Austin, C. P., Inglese, J., Harris, M. H., Asara, J. M., Stephanopoulos, G., Salituro, F. G., Jin, S., Dang, L., Auld, D. S., Park, H.-W., Cantley, L. C., Thomas, C. J., & Vander Heiden, M. G.
- Affiliations
- Beth Israel Deaconess Medical Center (US)
- Massachusetts Institute of Technology (US)
- National Institutes of Health (US)
- University of Toronto (CA)
- Agios Pharmaceuticals (United States) (US)
- University of California San Diego (US)
- Boston Children's Hospital (US)
- ORCID
- Anastasiou, Dimitrios
- Yu, Yimin
- Israelsen, William J
- Jiang, Jian-Kang
- Tempel, Wolfram
- Shen, Min
- Jha, Abhishek
- Yang, Hua
- Mattaini, Katherine R
- Metallo, Christian M
- Fiske, Brian P
- Courtney, Kevin D
- Khan, Tahsin M
- Southall, Noel
- Walsh, Martin J
- Brimacombe, Kyle R
- Lunt, Sophia Y
- Johnson, Zachary R
- Yen, Katharine E
- Kunii, Kaiko
- Davidson, Shawn M
- Christofk, Heather R
- Austin, Christopher P
- Inglese, James
- Harris, Marian H
- Asara, John M
- Stephanopoulos, Gregory
- Salituro, Francesco G
- Dang, Lenny
- Auld, Douglas S
- Park, Hee-Won
- Cantley, Lewis C
- Thomas, Craig J
- Venue
- Nature Chemical Biology
- Published
- 2012-08-26
- Volume
- 8
- Issue
- 10
- Pages
- 839-847
- ISSN
- 1552-4450 (ISSN-L)
- 1552-4469
- PMC
- PMC3711671
- OpenAlex
- W2125836344
- Cited by
- 816
- References
- 46
- Citations by year
- 2026: 39 · 2025: 76 · 2024: 61 · 2023: 66 · 2022: 59 · 2021: 73 · 2020: 69 · 2019: 47 · 2018: 60 · 2017: 49 · 2016: 53 · 2015: 55 · 2014: 55 · 2013: 45 · 2012: 9
- FWCI
- 17.46
- Type
- journal article
- Language
- en
- Update notices
- erratum (2012-11-26)
- Open access
- green
- europepmc.org
- Locations
- Nature Chemical Biology (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Digital Access to Scholarship at Harvard (DASH) (Harvard University) (submittedVersion, cc-by)
- UCL Discovery (University College London) (submittedVersion)
- eScholarship (California Digital Library) (submittedVersion)
- Funders
- Howard Hughes Medical Institute
- University of Chicago
- Genome Canada
- Wellcome Trust
- Knut och Alice Wallenbergs Stiftelse
- National Institutes of Health
- Canadian Institutes of Health Research
- National Institute of Mental Health (R03MH085679)
- National Cancer Institute (5P30CA1405141, R01CA160458, P01CA120964, P30CA006516)
- National Institute of General Medical Sciences (R01 GM56203, R01GM056203)
- Biological and Environmental Research
- Argonne National Laboratory
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Cancer, Hypoxia, and Metabolism
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Biochemical and Molecular Research
- Keywords
- PKM2, tetramerization, fructose-1,6-bisphosphate, small molecule activators, PKM1, tumor growth inhibition, tumor xenografts, cancer metabolism, glucose metabolism, tyrosine phosphorylation, anabolic metabolism, enzyme activation
- MeSH terms
- Animals, Biopolymers, Cell Transformation, Neoplastic, Humans, Neoplasms, Pyruvate Kinase, Blotting, Western, Enzyme Activators, Cell Proliferation, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
